Join to View Full Profile
1515 Holcombe BlvdHouston, TX 77030
Phone+1 713-792-6161
Dr. Kamat is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
University of Texas M D Anderson Cancer CenterFellowship, Complex General Surgical Oncology, 2001 - 2003
West Virginia UniversityChief Residency, Urology, 2000 - 2001- West Virginia UniversityResidency, Urology, 1997 - 2000
- West Virginia UniversityResidency, Surgery, 1995 - 1997
Seth G.S. Medical CollegeClass of 1994
Certifications & Licensure
FL State Medical License 2021 - Present
GA State Medical License 2023 - 2027
AZ State Medical License 2023 - 2026
LA State Medical License 2023 - 2026
MS State Medical License 2023 - 2026
OK State Medical License 2020 - 2026
TN State Medical License 2023 - 2026
American Board of Urology Urology- Join now to see all
Awards, Honors, & Recognition
- Compassionate Doctor Award
- Top Doctors in America
- Who's Who in Medicine
- Join now to see all
Clinical Trials
- Short-Term Low-Dose Interferon Alfa in Treating Patients With Cancer of the Urothelium Start of enrollment: 2003 Dec 01
- Markers of Response to Intravesical Bladder Cancer Therapy Start of enrollment: 2005 Jun 01
Publications & Presentations
PubMed
- Intravesical interferon-α2b gene therapy with nadofaragene firadenovec-vncg: a contemporary review.Taeweon Lee, Ayushi Gianchandani, Stephen A Boorjian, Neal D Shore, Vikram M Narayan
Future Oncology. 2025-07-10 - Hybrid 3-Tier Bladder Cancer Grade: The Mutually Beneficial Marriage of 2 Grading Systems.Ashish M Kamat, Bas W G van Rhijn, Theodorus Van der Kwast
The Journal of Urology. 2025-07-01 - International Society of Urological Pathology Consensus Meeting 2024: Working Group 2 Preneoplastic and Precursor Lesions of the Urinary Bladder.Michelle R Downes, Antonio Lopez-Beltran, Roberto Contieri, Donna E Hansel, Gladell P Paner
The American Journal of Surgical Pathology. 2025-07-01
Journal Articles
- Seminars Article New Horizons in Bladder Cancer ResearchStephen B Williams, Ashish M Kamat, ScienceDirect
- Utility of Bladder-Sparing Therapy vs Radical Cystectomy for Muscle-Invasive Bladder Cancer—ReplyAshish M Kamat, Stephen B Williams, JAMA
- Epidemiology of Bladder Cancer: A Systematic Review and Contemporary Update of Risk Factors in 2018Ashish M Kamat, Yair Lotan, European Urology
- Join now to see all
Authored Content
- Epidemiology of Bladder Cancer: A Systematic Review and Contemporary Update of Risk Factors in 2018September 2018
- Recommendations for Follow-up of Muscle-Invasive Bladder Cancer Patients: A Consensus by the International Bladder Cancer NetworkFebruary 2018
- Contribution of Bladder Cancer Pathology Assessment in Planning Clinical TrialsFebruary 2018
Press Mentions
International Validation of AI Tool for Stratifying Bladder Cancer Progression Risk - Jethro KwongMay 20th, 2025- NIAGARA Study: Durvalumab Improves DFS in Muscle-Invasive Bladder Cancer Post-Cystectomy - Joshua MeeksMay 14th, 2025
- Bladder Cancer Trial Finds Extended Lymph Node Surgery Doesn’t Improve SurvivalNovember 6th, 2024
- Join now to see all
Professional Memberships
- Member
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
